Works matching IS 02780232 AND DT 2022 AND VI 40 AND IP 4

Results: 36

Outcomes of second allogeneic stem cell transplantation and anti‐relapse strategies in patients with relapsed/refractory acute myeloid leukemia: A unicentric retrospective analysis.
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 763, doi. 10.1002/hon.2995
By:
- Shumilov, Evgenii;
- Hasenkamp, Justin;
- Maulhardt, Markus;
- Mazzeo, Paolo;
- Schmidt, Nicole;
- Boyadzhiev, Hristo;
- Jung, Wolfram;
- Ganster, Christina;
- Haase, Detlef;
- Koch, Raphael;
- Wulf, Gerald
Publication type:
Article
Prognostic utility of key copy number alterations in T cell acute lymphoblastic leukemia.
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 577, doi. 10.1002/hon.3030
By:
- Kumari, Sarita;
- Ali, M. Shadab;
- Singh, Jay;
- Arora, Mohit;
- Verma, Deepak;
- Pandey, Avanish Kumar;
- Benjamin, Mercilena;
- Bakhshi, Sameer;
- Palanichamy, Jayanth Kumar;
- Sharma, Atul;
- Singh, Inder;
- Tanwar, Pranay;
- Singh, Amar Ranjan;
- Pushpam, Deepam;
- Qamar, Imteyaz;
- Chopra, Anita
Publication type:
Article
Increased risk of nonrelapse mortality post T‐cell‐replete haploidentical stem cell transplantation in patients with recurrence of acute graft‐versus‐host disease.
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 743, doi. 10.1002/hon.2999
By:
- Peng, Bo;
- Dou, Liping;
- Yang, Jingjing;
- Wang, Lili;
- Li, Fei;
- Gao, Xiaoning;
- Wang, Shuhong;
- Jin, Xiangshu;
- Wang, Lu;
- Jia, Mingyu;
- Wang, Shenyu;
- Li, Yan;
- Liu, Daihong
Publication type:
Article
Reimagining diversity in multiple myeloma clinical trials.
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 689, doi. 10.1002/hon.2997
By:
- Habr, Dany;
- Corsaro, Massimo
Publication type:
Article
Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 3‐year follow‐up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials.
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 704, doi. 10.1002/hon.3031
By:
- Bruzzese, Antonella;
- Derudas, Daniele;
- Galli, Monica;
- Martino, Enrica Antonia;
- Rocco, Stefano;
- Conticello, Concetta;
- Califano, Catello;
- Giuliani, Nicola;
- Mangiacavalli, Silvia;
- Farina, Giuliana;
- Lombardo, Alessandra;
- Brunori, Marino;
- Rossi, Elena;
- Antonioli, Elisabetta;
- Ria, Roberto;
- Zambello, Renato;
- Di Renzo, Nicola;
- Mele, Giuseppe;
- Marcacci, Gianpaolo;
- Pietrantuono, Giuseppe
Publication type:
Article
Risk factors for cardiovascular events and mortality in patients diagnosed with diffuse large B‐cell lymphoma and treated with anthracyclines.
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 626, doi. 10.1002/hon.3034
By:
- Diamond, Akiva;
- Ayyappan, Sabarish;
- Cao, Shufen;
- Tashtish, Nour;
- Boughan, Kirsten;
- Cooper, Brenda;
- Fu, PingFu;
- Caimi, Paolo F.
Publication type:
Article
Outcome of therapy‐related myelodysplastic syndrome and oligoblastic acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: A propensity score matched analysis.
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 752, doi. 10.1002/hon.2991
By:
- Itonaga, Hidehiro;
- Kida, Michiko;
- Hamamura, Atsushi;
- Uchida, Naoyuki;
- Ozawa, Yukiyasu;
- Fukuda, Takahiro;
- Ueda, Yasunori;
- Kataoka, Keisuke;
- Katayama, Yuta;
- Ota, Shuichi;
- Matsuoka, Ken‐ichi;
- Kondo, Tadakazu;
- Eto, Tetsuya;
- Kanda, Junya;
- Ichinohe, Tatsuo;
- Atsuta, Yoshiko;
- Miyazaki, Yasushi;
- Ishiyama, Ken
Publication type:
Article
Baseline cluster of differentiation 22 fluorescent intensity correlates with patient outcome after Inotuzumab Ozogamicin treatment.
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 734, doi. 10.1002/hon.3029
By:
- Sartor, Chiara;
- Arpinati, Mario;
- Chirumbolo, Gabriella;
- Dozza, Luca;
- Cristiano, Gianluca;
- Nanni, Jacopo;
- Marconi, Giovanni;
- Robustelli, Valentina;
- Vigliotta, Ilaria;
- Parisi, Sarah;
- Terragna, Carolina;
- Testoni, Nicoletta;
- Paolini, Stefania;
- Martinelli, Giovanni;
- Curti, Antonio;
- Cavo, Michele;
- Papayannidis, Cristina
Publication type:
Article
Obinutuzumab does not improve complete methabolic response but does not compromise mobilization or engraftment of autologous peripheral blood stem cells in diffuse large B cell lymphoma: Results from a fondazione italiana linfomi prospective phase II study (the GIOTTO study)
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 609, doi. 10.1002/hon.3028
By:
- Rigacci, Luigi;
- Battistini, Roberta;
- Kovalchuk, Sofia;
- Zoli, Valerio;
- Puccini, Benedetta;
- Evangelista, Andrea;
- Arcaini, Luca;
- Flenghi, Leonardo;
- Visco, Carlo;
- Mian, Michael;
- Di Rocco, Alice;
- Peracchio, Claudia;
- Gotti, Manuel;
- Tisi, Maria Chiara;
- Palombi, Francesca;
- Pozzi, Samantha;
- Gioia, Daniela;
- Viero, Piera;
- Martelli, Maurizio
Publication type:
Article
Serum soluble CD23 levels are an independent predictor of time to first treatment in chronic lymphocytic leukemia.
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 588, doi. 10.1002/hon.3027
By:
- Piñeyroa, Juan A.;
- Magnano, Laura;
- Rivero, Andrea;
- Rivas‐Delgado, Alfredo;
- Nadeu, Ferran;
- Correa, Juan Gonzalo;
- Giné, Eva;
- Villamor, Neus;
- Filella, Xavier;
- Colomer, Dolors;
- López, Mònica;
- López‐Oreja, Irene;
- Costa, Dolors;
- Aymerich, Marta;
- Beà, Sílvia;
- López‐Guillermo, Armando;
- Campo, Elías;
- Delgado, Julio;
- Mozas, Pablo
Publication type:
Article
Ruxolitinib combined with prednisone, thalidomide and danazol in patients with myelofibrosis: Results of a pilot study.
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 787, doi. 10.1002/hon.3026
By:
- Qu, Shiqiang;
- Xu, Zefeng;
- Qin, Tiejun;
- Li, Bing;
- Pan, Lijuan;
- Chen, Jia;
- Yan, Xin;
- Wu, Junying;
- Zhang, Yudi;
- Zhang, Peihong;
- Gale, Robert Peter;
- Xiao, Zhijian
Publication type:
Article
Prognostic value of lesion dissemination in doxorubicin, bleomycin, vinblastine, and dacarbazine‐treated, interimPET‐negative classical Hodgkin Lymphoma patients: A radio‐genomic study.
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 645, doi. 10.1002/hon.3025
By:
- Durmo, Rexhep;
- Donati, Benedetta;
- Rebaud, Louis;
- Cottereau, Anne Segolene;
- Ruffini, Alessia;
- Nizzoli, Maria Elena;
- Ciavarella, Sabino;
- Vegliante, Maria Carmela;
- Nioche, Christophe;
- Meignan, Michel;
- Merli, Francesco;
- Versari, Annibale;
- Ciarrocchi, Alessia;
- Buvat, Irene;
- Luminari, Stefano
Publication type:
Article
Outcome of older myeloma patients in relationship to comorbidities and availability of second‐generation novel agents in a real‐life setting.
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 716, doi. 10.1002/hon.3024
By:
- Lalive d'Epinay, Murielle;
- Güsewell, Sabine;
- Graf, Nicole;
- Mey, Ulrich J. M.;
- Driessen, Christoph;
- Hitz, Felicitas
Publication type:
Article
Oral eltrombopag versus subcutaneous recombinant human thrombopoietin for promoting platelet engraftment after allogeneic stem cell transplantation: A prospective, non‐inferiority, randomized controlled trial.
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 777, doi. 10.1002/hon.3017
By:
- Wen, Bingbing;
- Zhang, Xiaohan;
- Chen, Shiyu;
- Fan, Jingchao;
- Yang, Sitian;
- Cai, Yun;
- Wang, Pengcheng;
- Zhang, Qiaoxia;
- Gu, Qingli;
- Du, Xin
Publication type:
Article
Combination of KIT and FLT3‐ITD mutation status with minimal residual disease levels guides treatment strategy for adult patients with inv(16) acute myeloid leukemia in first complete remission.
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 724, doi. 10.1002/hon.3015
By:
- Wang, Jun;
- Dao, Feng‐Ting;
- Wang, Yu;
- Jiang, Hao;
- Xu, Lan‐Ping;
- Zhao, Xiao‐Su;
- Zhang, Xiao‐Hui;
- Liu, Kai‐Yan;
- Huang, Xiao‐Jun;
- Jiang, Qian;
- Qin, Ya‐Zhen
Publication type:
Article
Targeting CD19 in diffuse large B‐cell lymphoma: An expert opinion paper.
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 505, doi. 10.1002/hon.3013
By:
- Bailly, Sarah;
- Cartron, Guillaume;
- Chaganti, Sridhar;
- Córdoba, Raul;
- Corradini, Paolo;
- Düll, Johannes;
- Ferrarini, Isacco;
- Osborne, Wendy;
- Rosenwald, Andreas;
- Sancho, Juan‐Manuel;
- Tilly, Hervé;
- Van Den Neste, Eric;
- Viardot, Andreas;
- Visco, Carlo
Publication type:
Article
Ibrutinib, lenalidomide and dexamethasone in patients with relapsed and/or refractory multiple myeloma: Phase I trial results.
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 695, doi. 10.1002/hon.3012
By:
- Ailawadhi, Sikander;
- Parrondo, Ricardo D.;
- Moustafa, Muhamad Alhaj;
- LaPlant, Betsy R.;
- Alegria, Victoria;
- Chapin, Dustin;
- Roy, Vivek;
- Sher, Taimur;
- Paulus, Aneel;
- Chanan‐Khan, Asher A.
Publication type:
Article
Immunomodulation mediated by polyclonal IgG replacement in patients with chronic lymphocytic leukemia may be important in infection prevention.
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 528, doi. 10.1002/hon.3011
By:
- Khan, Sujoy;
- Molica, Stefano;
- Allsup, David
Publication type:
Article
Anti‐CD47 immunotherapy in combination with BCL‐2 inhibitor to enhance anti‐tumor activity in B‐cell lymphoma.
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 596, doi. 10.1002/hon.3009
By:
- Li, Miaomiao;
- Yu, Hui;
- Qi, Fei;
- Ye, Yingying;
- Hu, Dingyao;
- Cao, Jiaowu;
- Wang, Dedao;
- Mi, Lan;
- Wang, Zhengyi;
- Ding, Ning;
- Ping, Lingyan;
- Shu, Shaokun;
- Zhu, Jun
Publication type:
Article
B‐cell activating factor (BAFF), BAFF promoter and BAFF receptor allelic variants in hepatitis C virus related Cryoglobulinemic Vasculitis and Non‐Hodgkin's Lymphoma.
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 658, doi. 10.1002/hon.3008
By:
- Gragnani, Laura;
- Lorini, Serena;
- Marri, Silvia;
- Rattotti, Sara;
- Madia, Francesco;
- Zibellini, Silvia;
- Monti, Monica;
- Basile, Umberto;
- Di Stasio, Enrico;
- Libra, Massimo;
- Arcaini, Luca;
- Zignego, Anna Linda
Publication type:
Article
The potential efficacy and mechanism of bendamustine in entra‐nodal NK/T cell lymphoma.
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 678, doi. 10.1002/hon.3007
By:
- Gao, Yuyang;
- Feng, Xiaoyan;
- Song, Wenting;
- Li, Hongwen;
- Shi, Cunzhen;
- Jin, Mengyuan;
- Li, Zhaoming;
- Zhang, Lei;
- Zhang, Mingzhi
Publication type:
Article
The "m6A writer" METTL3 and the "m6A reader" IGF2BP2 regulate cutaneous T‐cell lymphomas progression via CDKN2A.
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 567, doi. 10.1002/hon.3005
By:
- Wang, Xinchen;
- Hu, Maogui;
- Yu, Lu;
- Wang, Xiaoyan;
- Jiang, Xinlu;
- Zhang, Guihong;
- Ding, Kaiyang
Publication type:
Article
LncRNA FIRRE stimulates PTBP1‐induced Smurf2 decay, stabilizes B‐cell receptor, and promotes the development of diffuse large B‐cell lymphoma.
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 554, doi. 10.1002/hon.3004
By:
- Liu, Qin‐Hua;
- Dai, Guan‐Rong;
- Wu, Yi;
- Wang, Xiao‐Nan;
- Song, Ming‐Yue;
- Li, Xiao‐Dan;
- Wu, Zhengsheng;
- Xia, Rui‐Xiang
Publication type:
Article
High inter‐follicular spatial co‐localization of CD8+FOXP3+ with CD4+CD8+ cells predicts favorable outcome in follicular lymphoma.
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 541, doi. 10.1002/hon.3003
By:
- Hagos, Yeman B.;
- Akarca, Ayse U.;
- Ramsay, Alan;
- Rossi, Riccardo L.;
- Pomplun, Sabine;
- Ngai, Victoria;
- Moioli, Alessia;
- Gianatti, Andrea;
- Mcnamara, Christopher;
- Rambaldi, Alessandro;
- Quezada, Sergio A.;
- Linch, David;
- Gritti, Giuseppe;
- Yuan, Yinyin;
- Marafioti, Teresa
Publication type:
Article
Perspective: Pivotal translational hematology and therapeutic insights in chronic myeloid hematopoietic stem cell malignancies.
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 491, doi. 10.1002/hon.2987
By:
- Mughal, Tariq I.;
- Pemmaraju, Naveen;
- Bejar, Rafael;
- Gale, Robert P.;
- Bose, Prithviraj;
- Kiladjian, Jean‐Jacques;
- Prchal, Josef;
- Royston, Daniel;
- Pollyea, Daniel;
- Valent, Peter;
- Brümmendorf, Tim H.;
- Skorski, Tomasz;
- Patnaik, Mrinal;
- Santini, Valeria;
- Fenaux, Pierre;
- Kucine, Nicole;
- Verstovsek, Srdan;
- Mesa, Ruben;
- Barbui, Tiziano;
- Saglio, Guiseppe
Publication type:
Article
Phase II study of fixed‐duration single‐agent ibrutinib in relapsed nodular lymphocyte‐predominant Hodgkin lymphoma: A report from the German Hodgkin Study Group.
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 801, doi. 10.1002/hon.2986
By:
- Eichenauer, Dennis A.;
- Bühnen, Ina;
- Plütschow, Annette;
- Kobe, Carsten;
- Dietlein, Markus;
- Wendtner, Clemens‐Martin;
- Thorspecken, Sven;
- Topp, Max S.;
- Mauser, Mareike;
- von Tresckow, Bastian;
- Fuchs, Michael;
- Borchmann, Peter;
- Engert, Andreas
Publication type:
Article
"Accelerated phase" chronic lymphocytic leukemia: Still an intermediate risk disease in the era of targeted therapies.
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 805, doi. 10.1002/hon.2985
By:
- Lapierre, Léopoldine;
- Syrykh, Charlotte;
- Largeaud, Laetitia;
- Cabarrou, Bastien;
- Filleron, Thomas;
- Oberic, Lucie;
- Kanoun, Salim;
- Coster, Lucie;
- Laurent, Camille;
- Branco, Benoît;
- Gadaud, Noémie;
- Récher, Christian;
- Brechemier, Delphine;
- Balardy, Laurent;
- Vergez, François;
- Ysebaert, Loïc;
- Gauthier, Martin
Publication type:
Article
Use of BTK inhibitors with focus on ibrutinib in mantle cell lymphoma: An expert panel opinion statement.
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 518, doi. 10.1002/hon.2983
By:
- Zinzani, Pier Luigi;
- Martelli, Maurizio;
- Ferrero, S.;
- Gentile, Massimo;
- Laurenti, Luca;
- Romana Mauro, Francesca;
- Sportoletti, Paolo;
- Tedeschi, Alessandra;
- Varettoni, M.;
- Visco, Carlo
Publication type:
Article
Long‐term outcomes and central nervous system relapse in extranodal natural killer/T‐cell lymphoma.
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 667, doi. 10.1002/hon.2977
By:
- Miyazaki, Kana;
- Suzuki, Ritsuro;
- Oguchi, Masahiko;
- Taguchi, Senzo;
- Amaki, Jun;
- Maeda, Takeshi;
- Kubota, Nobuko;
- Maruyama, Dai;
- Terui, Yasuhito;
- Sekiguchi, Nodoka;
- Takizawa, Jun;
- Tsukamoto, Hiroyuki;
- Murayama, Tohru;
- Ando, Toshihiko;
- Matsuoka, Hiroshi;
- Hasegawa, Masatoshi;
- Wada, Hideho;
- Sakai, Rika;
- Kameoka, Yoshihiro;
- Tsukamoto, Norifumi
Publication type:
Article
Chidamide with PEL regimen (prednisone, etoposide, lenalidomide) for elderly or frail patients with relapsed/refractory diffuse large B‐Cell lymphoma ‐results of a single center, retrospective cohort in China.
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 617, doi. 10.1002/hon.2979
By:
- Wang, Yawen;
- Xue, Hongwei;
- Song, Wei;
- Xiao, Shuxin;
- Jing, Fanjing;
- Dong, Tieying;
- Wang, Lili
Publication type:
Article
Chimeric antigen receptor T‐cell therapy combined with autologous stem cell transplantation improved progression‐free survival of relapsed or refractory diffuse large B‐cell lymphoma patients: A single‐center, retrospective, cohort study
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 637, doi. 10.1002/hon.2975
By:
- Wang, Tao;
- Xu, Lili;
- Gao, Lei;
- Tang, Gusheng;
- Chen, Li;
- Chen, Jie;
- Wang, Yang;
- Fu, Weijia;
- Yue, Wenqin;
- Ye, Mingyu;
- Yu, Jiechen;
- Yu, Xuejun;
- Feng, Dongge;
- Zhang, Aiping;
- Yang, Jianmin
Publication type:
Article
Clinicopathological analysis of immunohistochemical expression of immune checkpoint molecules in follicular lymphoma.
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 530, doi. 10.1002/hon.2972
By:
- Yanagida, Eriko;
- Miyoshi, Hiroaki;
- Takeuchi, Mai;
- Shimono, Joji;
- Nakashima, Kazutaka;
- Yamada, Kyohei;
- Kawamoto, Keisuke;
- Moritsubo, Mayuko;
- Shimasaki, Yasumasa;
- Inoue, Kanako;
- Imamoto, Teppei;
- Furuta, Takuya;
- Kohno, Kei;
- Ohshima, Koichi
Publication type:
Article
A study of Telomerase Reverse Transcriptase rare variants in myeloid neoplasia.
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 812, doi. 10.1002/hon.2967
By:
- Gurnari, Carmelo;
- Wahida, Adam;
- Pagliuca, Simona;
- Durmaz, Arda;
- Zawit, Misam;
- Haferlach, Torsten;
- Maciejewski, Jaroslaw P.;
- Visconte, Valeria
Publication type:
Article
Prognostic value of FDG‐PET/CT response for patient selection before chimeric antigen receptor‐T‐cells therapy in non‐Hodgkin lymphoma.
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 796, doi. 10.1002/hon.2965
By:
- Bailly, Clément;
- Carlier, Thomas;
- Tessoulin, Benoit;
- Gastinne, Thomas;
- Kraeber‐Bodere, Françoise;
- Le Gouill, Steven;
- Bodet‐Milin, Caroline
Publication type:
Article
Native E. coli asparaginase upfront should be replaced by PEGasparaginase upfront in the treatment of pediatric patients with acute lymphoblastic leukemia.
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 809, doi. 10.1002/hon.2960
By:
- Tong, Wing H.;
- Mesegué, Montserrat;
- Dapena, José Luís;
- Camós, Mireia;
- Rives, Susana
Publication type:
Article
Issue Information.
Published in:
Hematological Oncology, 2022, v. 40, n. 4, p. 489, doi. 10.1002/hon.2892
Publication type:
Article